☰

Ksenia V. Kastanenka, Ph.D. - Publications

Affiliations: 
2011 Neurosciences Case Western Reserve University, Cleveland Heights, OH, United States 
Area:
neural development, transmission, plasticity
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

24 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Zhao Q, Maci M, Miller MR, Zhou H, Zhang F, Algamal M, Lee YF, Hou SS, Perle SJ, Le H, Russ AN, Lo EH, Gerashchenko D, Gomperts SN, Bacskai BJ, ... Kastanenka KV, et al. Sleep restoration by optogenetic targeting of GABAergic neurons reprograms microglia and ameliorates pathological phenotypes in an Alzheimer's disease model. Molecular Neurodegeneration. 18: 93. PMID 38041158 DOI: 10.1186/s13024-023-00682-9  0.559
2023 Lee YF, Russ AN, Zhao Q, Perle SJ, Maci M, Miller MR, Hou SS, Algamal M, Zhao Z, Li H, Gelwan N, Liu Z, Gomperts SN, Araque A, Galea E, ... ... Kastanenka KV, et al. Optogenetic targeting of astrocytes restores slow brain rhythm function and slows Alzheimer's disease pathology. Scientific Reports. 13: 13075. PMID 37567942 DOI: 10.1038/s41598-023-40402-3  0.628
2023 Lee YF, Russ AN, Zhao Q, Maci M, Miller MR, Hou SS, Algamal M, Zhao Z, Li H, Gelwan N, Gomperts SN, Araque A, Galea E, Bacskai BJ, Kastanenka KV. Optogenetic Targeting of Astrocytes Restores Slow Brain Rhythm Function and Slows Alzheimer's Disease Pathology. Research Square. PMID 37163040 DOI: 10.21203/rs.3.rs-2813056/v1  0.627
2023 Miller MR, Lee YF, Kastanenka KV. Calcium sensor Yellow Cameleon 3.6 as a tool to support the calcium hypothesis of Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 37154246 DOI: 10.1002/alz.13111  0.318
2022 Algamal M, Russ AN, Miller MR, Hou SS, Maci M, Munting LP, Zhao Q, Gerashchenko D, Bacskai BJ, Kastanenka KV. Reduced excitatory neuron activity and interneuron-type-specific deficits in a mouse model of Alzheimer's disease. Communications Biology. 5: 1323. PMID 36460716 DOI: 10.1038/s42003-022-04268-x  0.623
2022 Thankachan S, Gerashchenko A, Kastanenka KV, Bacskai BJ, Gerashchenko D. Optimization of real-time analysis of sleep-wake cycle in mice. Methodsx. 9: 101811. PMID 36065218 DOI: 10.1016/j.mex.2022.101811  0.476
2022 Thankachan S, Yang C, Kastanenka KV, Bacskai BJ, Gerashchenko D. Low frequency visual stimulation enhances slow wave activity without disrupting the sleep pattern in mice. Scientific Reports. 12: 12278. PMID 35853986 DOI: 10.1038/s41598-022-16478-8  0.548
2021 Lee YF, Lariviere L, Russ AN, Choi SZ, Bacskai BJ, Kastanenka KV. Novel botanical therapeutic NB-02 effectively treats Alzheimer's neuropathophysiology in an APP/PS1 mouse model. Eneuro. PMID 33926907 DOI: 10.1523/ENEURO.0389-20.2021  0.624
2020 Lee YF, Gerashchenko D, Timofeev I, Bacskai BJ, Kastanenka KV. Slow Wave Sleep Is a Promising Intervention Target for Alzheimer's Disease. Frontiers in Neuroscience. 14: 705. PMID 32714142 DOI: 10.3389/Fnins.2020.00705  0.659
2019 Kastanenka KV, Calvo-Rodriguez M, Hou SS, Zhou H, Takeda S, Arbel-Ornath M, Lariviere A, Lee YF, Kim A, Hawkes JM, Logan R, Feng D, Chen X, Gomperts SN, Bacskai BJ. Frequency-dependent exacerbation of Alzheimer's disease neuropathophysiology. Scientific Reports. 9: 8964. PMID 31221985 DOI: 10.1038/S41598-019-44964-Z  0.733
2018 György B, Lööv C, Zaborowski MP, Takeda S, Kleinstiver BP, Commins C, Kastanenka K, Mu D, Volak A, Giedraitis V, Lannfelt L, Maguire CA, Joung JK, Hyman BT, Breakefield XO, et al. CRISPR/Cas9 Mediated Disruption of the Swedish APP Allele as a Therapeutic Approach for Early-Onset Alzheimer's Disease. Molecular Therapy. Nucleic Acids. 11: 429-440. PMID 29858078 DOI: 10.1016/J.Omtn.2018.03.007  0.427
2018 Wang X, Kastanenka KV, Arbel-Ornath M, Commins C, Kuzuya A, Lariviere AJ, Krafft GA, Hefti F, Jerecic J, Bacskai BJ. An acute functional screen identifies an effective antibody targeting amyloid-β oligomers based on calcium imaging. Scientific Reports. 8: 4634. PMID 29545579 DOI: 10.1038/S41598-018-22979-2  0.637
2018 Pagnier GJ, Kastanenka KV, Sohn M, Choi S, Choi SH, Soh H, Bacskai BJ. Novel botanical drug DA-9803 prevents deficits in Alzheimer's mouse models. Alzheimer's Research & Therapy. 10: 11. PMID 29378621 DOI: 10.1186/S13195-018-0338-2  0.624
2017 Maesako M, Horlacher J, Zoltowska KM, Kastanenka KV, Kara E, Svirsky S, Keller LJ, Li X, Hyman BT, Bacskai BJ, Berezovska O. Pathogenic PS1 phosphorylation at Ser367. Elife. 6. PMID 28132667 DOI: 10.7554/Elife.19720  0.561
2017 Kastanenka KV, Hou SS, Shakerdge N, Logan R, Feng D, Wegmann S, Chopra V, Hawkes JM, Chen X, Bacskai BJ. Optogenetic Restoration of Disrupted Slow Oscillations Halts Amyloid Deposition and Restores Calcium Homeostasis in an Animal Model of Alzheimer's Disease. Plos One. 12: e0170275. PMID 28114405 DOI: 10.1371/Journal.Pone.0170275  0.67
2016 Kastanenka KV, Bussiere T, Shakerdge N, Qian F, Weinreb PH, Rhodes K, Bacskai BJ. Immunotherapy with aducanumab restores calcium homeostasis in Tg2576 mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 27810931 DOI: 10.1523/Jneurosci.2080-16.2016  0.613
2016 Maesako M, Horlacher J, Zoltowska KM, Kastanenka KV, Kara E, Svirsky S, Keller LJ, Li X, Hyman BT, Bacskai BJ, Berezovska O. Author response: Pathogenic PS1 phosphorylation at Ser367 Elife. DOI: 10.7554/Elife.19720.023  0.477
2016 Kastanenka K, Bussière T, Wang X, Hou S, Arbel M, Takeda S, Commins C, Qian F, Weinreb P, Rhodes K, Bacskai B. P1-033: Aducanumab Targets High Molecular Weight Soluble Aβ Oligomers and Restores Calcium to Normal Levels in TG2576 Mice Alzheimer's & Dementia. 12: P413-P414. DOI: 10.1016/J.Jalz.2016.06.780  0.6
2015 Dumurgier J, Schraen S, Gabelle A, Vercruysse O, Bombois S, Laplanche JL, Peoc'h K, Sablonnière B, Kastanenka KV, Delaby C, Pasquier F, Touchon J, Hugon J, Paquet C, Lehmann S. Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study. Alzheimer's Research & Therapy. 7: 30. PMID 26034513 DOI: 10.1186/S13195-015-0114-5  0.381
2014 Wang X, Arbel-Ornath M, Wegmann SK, Kastanenka KV, Bacskai BJ. In vivo imaging in neurodegenerative diseases Advances in Intravital Microscopy: From Basic to Clinical Research. 45-80. DOI: 10.1007/978-94-017-9361-2_3  0.459
2013 Kastanenka KV, Landmesser LT. Optogenetic-mediated increases in in vivo spontaneous activity disrupt pool-specific but not dorsal-ventral motoneuron pathfinding. Proceedings of the National Academy of Sciences of the United States of America. 110: 17528-33. PMID 24101487 DOI: 10.1073/Pnas.1316457110  0.596
2013 Kastanenka K, Bussiere T, Weinreb P, Qian F, Rhodes K, Bacskai B. P2-411: Amelioration of calcium dyshomeostasis by immunotherapy with BIIB037 in Tg2576 mice Alzheimer's & Dementia. 9: P508-P508. DOI: 10.1016/J.Jalz.2013.05.1061  0.543
2011 Maeno-Hikichi Y, Polo-Parada L, Kastanenka KV, Landmesser LT. Frequency-dependent modes of synaptic vesicle endocytosis and exocytosis at adult mouse neuromuscular junctions. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 1093-105. PMID 21248134 DOI: 10.1523/Jneurosci.2800-10.2011  0.586
2010 Kastanenka KV, Landmesser LT. In vivo activation of channelrhodopsin-2 reveals that normal patterns of spontaneous activity are required for motoneuron guidance and maintenance of guidance molecules. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 10575-85. PMID 20686000 DOI: 10.1523/Jneurosci.2773-10.2010  0.571
Show low-probability matches.